Skip to content
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Home Link (JNJ Logo)
Heart icon (animated) heart icon (static)
Our Stories
Our Company
Follow Us
Explore more Johnson & Johnson sites:
Australia
A graphic of the flag of Australia alt
Argentina
A graphic of the flag of Argentina alt
Brazil
A graphic of the flag of Brazil alt
Canada
A graphic of the national flag of Canada alt
Chile
A graphic of the flag of Chile alt
China
A graphic of the national flag of the People's Republic of China alt
Colombia
A graphic of the national flag of Colombia alt
Costa Rica
A graphic of the national flag of Costa Rica alt
Czech Republic
Ecuador
A graphic of the national flag of Ecuador alt
Germany
A graphic of the flag of Germany alt
India
A graphic of the national flag of India alt
Japan
A graphic of the national flag of Japan alt
Mexico
A graphic of the flag of Mexico alt
New Zealand / Pacific
A graphic of the flag of New Zealand alt
Paraguay
A graphic of the flag of Paraguay alt
Peru
A graphic of the flag of Peru alt
Philippines
A graphic of the national flag of the Philippines alt
Russia
A graphic of the flag of Russia alt
Switzerland
A graphic of the flag of Switzerland alt
German
English
French
United States
A graphic of the flag of the United States of America alt
Uruguay
A graphic of the national flag of Uruguay alt
Venezuela
A graphic of the flag of Venezuela alt
Share

Media Center

Learn More
Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use
Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use
Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial
COVID-19 Update: Your Latest Questions About Johnson & Johnson's Investigational Vaccine Candidate Answered
Johnson & Johnson Announces Agreement in Principle with Gavi to Supply Janssen’s COVID-19 Vaccine Candidate
to Lower-Income Countries in 2021
Have Questions About Participating in a COVID-19 Vaccine Clinical Trial? A Doctor Overseeing a Study Helps Answer Them

Latest Press Releases

Our Company
February 27, 2021
Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use
Our Company
February 26, 2021
Johnson & Johnson Single-Shot COVID-19 Vaccine Candidate Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee
Innovation
February 24, 2021
Janssen Announces Submission of Supplemental New Drug Application to U.S. FDA by ViiV Healthcare for Expanded Use of CABENUVA (rilpivirine and cabotegravir) as an HIV Treatment for Use Every Two Months
Our Company
February 19, 2021
Johnson & Johnson Announces Submission to World Health Organization for Emergency Use Listing of Investigational Single-Shot Janssen COVID-19 Vaccine Candidate
Our Company
February 16, 2021
Johnson & Johnson Announces Submission of European Conditional Marketing Authorisation Application to the EMA for its Investigational Single-Shot Janssen COVID-19 Vaccine Candidate
Innovation
February 08, 2021
Janssen Announces Treatment with ERLEADA® (apalutamide) Significantly Improved Overall Survival in Patients with Metastatic Castration-Sensitive Prostate Cancer
See All Press Releases

Photos, Videos, Infographics & More

See All

J&J Fast Facts

Our Company
We Work All Over the World
We Work All Over the World
We have over 134,000 employees working across more than 260 operating companies located in 60 countries around the world.
Get to know Johnson & Johnson
See All Fast Facts

Social Media

  • Black people are far more likely to live with cardiovascular diseases than other U.S. populations. Uncover three ey… https://t.co/VIDV6jTQv8
    JNJNews
  • Native Americans and Black & Hispanic Americans are dying of #COVID19 at nearly three times the rate of white peopl… https://t.co/LOxP9BoZSr
    JNJNews
  • Which of the below could trigger an #AFib episode? This #AmericanHeartMonth, get the answer to this question and l… https://t.co/lYnW4OgAgY
    JNJNews
Follow Us On Twitter

More From Johnson & Johnson

This site uses cookies as described in our Cookie Policy. Please click the "Accept" button or continue to use our site if you agree to our use of cookies.
Close cookie banner icon
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.
Continue